Glucan drug delivery system and adjuvant
AssigneeAlpha-Beta Technology, Inc.
InventorsSpiros Jamas, Gary R. Ostroff, D. Davidson Easson, Jr.
Life of this patent
Estimating the term…
Abstract
The invention describes a whole .beta.-glucan drug delivery vehicle that non-specifically enhances the immune response, and is safe for human use. A drug is incorporated into a whole .beta.-glucan microparticle, and the combination is administered to an individual. The .beta.-glucan vehicle allows sustained release of the drug component while simultaneously enhancing the effectiveness of the drug by boosting the individual's endogenous immune response.
Claims6
A bioerodible pharmaceutical composition for administration to a mammal comprising:
- a. whole glucan particles comprising .beta.(1-6) and .beta.(1-3) linked glucans;
- and
- b. a protein;
- wherein said protein is contained within said whole glucan particles, which composition, when placed in a physiological environment, releases the protein over time into the physiological environment and wherein said whole glucan particles bioerode in the physiological environment, which whole glucan particles stimulate a nonspecific immune response in the mammal, thereby providing an adjuvant effect.
A therapeutic composition comprising:
- a. bioerodible whole glucan particles comprising .beta.(1-6) and .beta.(1-3) linked glucans;
- and
- b. an antigen or an antigenic determinant
- contained within the whole glucan particles, wherein the antigen or antigen determinant is released from the glucan over time, the glucan particles bioerode in the physiological environment, the wherein the composition stimulates an immune response in the mammal.
A method of vaccinating a mammal comprising:
- administrating to the mammal a composition comprising a vaccine contained within whole glucan particles, whereby the vaccine is continuously released from the whole glucan particle and wherein the whole glucan particle stimulates an immune response in the mammal thereby enhancing the action of the vaccine.
A bioerodible pharmaceutical composition for administration to a mammal comprising:
- a. whole glucan particles comprising .beta.(1-6) and .beta.(-3) linked glucans;
- and
- b. an antigen or antigenic determinant;
- wherein the whole glucan particles are specific for macrophages;
- wherein the glucan particles are bioeroded within the macrophages thereby activating said macrophages;
- and wherein the composition releases the antigen or antigenic determinant in or near the macrophages thereby resulting in an enhanced immune response to the antigen or antigenic determinant.
Dependencies are inferred from the claim text.